IRIS
MOTTA, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.995
AS - Asia 2.721
EU - Europa 2.254
SA - Sud America 348
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 4
Totale 25.379
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.932
SG - Singapore 1.371
CN - Cina 483
IT - Italia 449
BR - Brasile 296
DE - Germania 273
UA - Ucraina 263
RU - Federazione Russa 256
KR - Corea 217
HK - Hong Kong 216
VN - Vietnam 200
IE - Irlanda 184
GB - Regno Unito 156
FR - Francia 154
SE - Svezia 150
PL - Polonia 104
FI - Finlandia 89
NL - Olanda 74
JP - Giappone 70
CA - Canada 44
IN - India 42
AR - Argentina 28
AT - Austria 23
ZA - Sudafrica 19
TR - Turchia 16
CZ - Repubblica Ceca 14
UZ - Uzbekistan 14
BE - Belgio 13
ES - Italia 13
EU - Europa 13
IQ - Iraq 13
ID - Indonesia 11
BD - Bangladesh 9
MX - Messico 9
EC - Ecuador 7
SA - Arabia Saudita 7
KE - Kenya 6
LT - Lituania 6
PK - Pakistan 6
AE - Emirati Arabi Uniti 5
DK - Danimarca 5
IL - Israele 5
TN - Tunisia 5
AU - Australia 4
EG - Egitto 4
PH - Filippine 4
PY - Paraguay 4
RO - Romania 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CL - Cile 3
IR - Iran 3
KZ - Kazakistan 3
NP - Nepal 3
RS - Serbia 3
TW - Taiwan 3
UY - Uruguay 3
AL - Albania 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
CR - Costa Rica 2
DM - Dominica 2
DZ - Algeria 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
TH - Thailandia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SN - Senegal 1
Totale 25.379
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.497
Wilmington 5.199
Houston 4.498
Fairfield 628
Singapore 606
Ann Arbor 410
Ashburn 367
Chandler 348
San Jose 274
Seattle 232
Hong Kong 212
Jacksonville 207
Beijing 204
Cambridge 187
Dublin 175
Rome 161
Medford 137
Council Bluffs 121
Dearborn 104
Santa Clara 97
New York 91
Kraków 78
The Dalles 77
Los Angeles 75
Lawrence 65
Ho Chi Minh City 63
Tokyo 57
Hanoi 51
Lauterbourg 48
San Diego 46
Munich 44
Zhengzhou 44
Buffalo 42
Moscow 41
Dallas 39
Manchester 32
Helsinki 31
Milan 31
Chicago 30
Norwalk 29
São Paulo 26
London 24
Maastricht 23
Menlo Park 19
Palo Alto 19
Warsaw 19
Mülheim 17
Chennai 16
Düsseldorf 16
Johannesburg 16
Orem 16
Hangzhou 15
Redondo Beach 15
Redwood City 15
Vienna 15
Brno 13
Brussels 13
Amsterdam 12
Belo Horizonte 12
Hefei 12
Mountain View 12
Seoul 12
Boardman 11
Brooklyn 11
Salt Lake City 11
Tashkent 11
University Park 11
Atlanta 10
Da Nang 10
Frankfurt am Main 10
Nanjing 10
Nuremberg 10
Phoenix 10
Rio de Janeiro 10
Verona 10
Denver 9
Madrid 9
Montreal 9
Philadelphia 9
Pieve a Nievole 9
Poplar 9
San Francisco 9
Guangzhou 8
Kunming 8
Mumbai 8
Stockholm 8
Turku 8
Eijsden 7
Haiphong 7
Naples 7
Ankara 6
Boston 6
Elk Grove Village 6
Ferrara 6
Mcallen 6
North Bergen 6
Saint Petersburg 6
Toronto 6
Utrecht 6
Biên Hòa 5
Totale 21.353
Salva come PNG Salva come JPEG
Nome #
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 606
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 574
Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration 515
Transcranial magnetic stimulation of the precuneus enhances memory and neural activity in prodromal Alzheimer's disease 515
Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes 499
Growth factors and synaptic plasticity in relapsing-remitting multiple sclerosis 493
Subclinical central inflammation is risk for RIS and CIS conversion to MS 476
Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis 476
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis 474
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis 468
Gabaergic and glutamatergic synaptic transmissions are altered after cuprizone exposure: implication for schizophrenia and demyelinating diseases 467
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability 466
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment 462
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53 459
Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis 453
Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS 452
Sympathetic autonomic system is differentially altered in progressive and relapsing multiple sclerosis 450
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter 448
Interleukin-8 is associated with acute and persistent dysfunction after optic neuritis 446
Inflammation inhibits GABA transmission in multiple sclerosis 438
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation 438
The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission 438
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis 438
Disability and its progression can be objectively measured in multiple sclerosis 437
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis 436
Interleukin-1β Causes Anxiety by Interacting with the Endocannabinoid System 432
Transient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis 423
Neural stem cell transplantation promotes post-ischemic neuronal plasticity by regulating the expression of glutamate transporters 422
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis 420
Endovascular Stroke Treatment of Acute Tandem Occlusion: A Single-Center Experience 420
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis 419
The autonomic balance predicts cardiac responses after the first dose of fingolimod 416
CT angiography-based collateral flow and time to reperfusion are strong predictors of outcome in endovascular treatment of patients with stroke 412
Plasmacytoid dendritic cells induce an immunoregulatory T helper 9 profile in multiple sclerosis 409
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis 407
Efficacy and Safety of Mechanical Thrombectomy in Older Adults with Acute Ischemic Stoke 407
Glatiramer acetate protects against inflammatory synaptopathy in experimental autoimmune encephalomyelitis 405
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis 402
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis 397
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 396
Effect of Glatiramer acetate on disease reactivation in MS patients discontinuing natalizumab 392
Interleukin-1β alters the sensitivity of cannabinoid CB1 receptors controlling glutamate transmission in the striatum 388
TNF-α-mediated anxiety in a mouse model of multiple sclerosis 383
Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis 382
Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis 381
CT angiography ASPECTS predicts outcome much better than noncontrast CT in patients with stroke treated endovascularly 378
Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis 373
Pretreatment predictors of malignant evolution in patients with ischemic stroke undergoing mechanical thrombectomy 371
Proposed chronic cerebrospinal venous insufficienty criteria do not predict multiple sclerosis risk or severity 362
Long-term potentiation-like cortical plasticity is disrupted in Alzheimer's disease patients independently from age of onset 350
CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer's disease 342
Is cerebral glucose metabolism related to blood-brain barrier dysfunction and intrathecal IgG synthesis in Alzheimer disease? A 18F-FDG PET/CT study 310
Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia 252
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial 236
Heparin during endovascular stroke treatment seems safe 203
LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients. 195
Management of flu-like syndrome with cetirizine in patients with relapsing-remitting multiple sclerosis during therapy with interferon beta: Results of a randomized, cross-over, placebo-controlled pilot study 179
Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial 174
LTP-like cortical plasticity predicts conversion to dementia in patients with memory impairment 168
Protective role of cerebrospinal fluid inflammatory cytokines in patients with amnestic mild cognitive impairment and early Alzheimer's disease carrying apolipoprotein E4 genotype 158
Clinical and histological study of a xenogenic bone substitute used as a filler in postextractive alveolus 152
Effects of cerebellar theta burst stimulation on contralateral motor cortex excitability in patients with Alzheimer’s disease 145
Cognitive reserve and Alzheimer's biological continuum: clues for prediction and prevention of dementia 122
Brain energy metabolism and neurodegeneration: hints from CSF lactate levels in dementias 112
Diabetes Mellitus contributes to higher cerebrospinal fluid tau levels selectively in Alzheimer's disease patients with APOE4 genotype 105
Blood–brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer's disease 100
Autonomic Dysfunction in Patients With Dementia With Lewy Bodies and Its Relationship With Nigrostriatal Denervation 99
Effects of 52 weeks of precuneus rTMS in Alzheimer's disease patients: a randomized trial 92
Isolated amyloid-β pathology is associated with preserved cortical plasticity in APOE4 Alzheimer's disease patients 92
Decreased Frontal Gamma Activity in Alzheimer Disease Patients 90
Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study 90
Functional correlates of microglial and astrocytic activity in symptomatic sporadic Alzheimer's disease: a CSF/18F-FDG-PET study 79
Improving visuo-motor learning with cerebellar theta burst stimulation: behavioral and neurophysiological evidence 65
Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients 62
Biobanking for Neurodegenerative Diseases: Challenge for Translational Research and Data Privacy 58
Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer's Disease 57
Intermittent cerebellar theta burst stimulation improves visuo-motor learning in stroke patients: a pilot study 55
Rethinking dementia in the oldest old: Lessons to learn for the diagnosis and treatment of Alzheimer’s disease 30
Reply to: letter to the editor regarding “beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies” 25
Beyond memory: leveraging CSF biomarkers in all MCI patients ahead of anti-amyloid therapies 24
Elevated plasma p-tau217 in newborns: developmental signal or synaptic stress marker? 23
Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum. 21
Interplay between the catecholaminergic enzymatic axis and neurodegeneration/neuroinflammation processes in the Alzheimer's disease continuum 19
Reframing TDP‐43 in Alzheimer's disease: From co‐pathology to neurovascular culprit 18
Lecanemab’s Path Forward: Navigating the Future of Alzheimer’s Treatment in Europe Amidst the EMA's Rejection 16
Totale 25.739
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.280
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 0 0 0 0 0 140 31
2021/2022772 40 98 75 37 26 84 36 28 54 55 50 189
2022/2023850 119 90 20 103 73 187 62 49 63 12 53 19
2023/2024254 37 7 22 12 22 70 12 4 3 5 8 52
2024/20252.154 66 374 179 113 74 256 112 89 149 176 321 245
2025/20263.074 249 161 373 262 312 124 460 357 457 281 38 0
Totale 25.739